<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Phospholipase A(2) (<z:chebi fb="79" ids="53407">PLA</z:chebi>(2)), cyclooxygenase (COX) and <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> (PG) synthase are enzymes involved in <z:chebi fb="0" ids="32395">arachidonate</z:chebi> cascade </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="79" ids="53407">PLA</z:chebi>(2) liberates <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> (AA) from cell membrane <z:chebi fb="23" ids="18059">lipids</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>COX oxidizes AA to <z:chebi fb="0" ids="48622">PGG</z:chebi>(2) followed by an endoperoxidase reaction that converts <z:chebi fb="0" ids="48622">PGG</z:chebi>(2) into <z:chebi fb="0" ids="26344">PGH</z:chebi>(2) </plain></SENT>
<SENT sid="3" pm="."><plain>PGs are generated from astrocytes, microglial cells and neurons in the central <z:mp ids='MP_0008912'>nervous</z:mp> system, and are altered in the brain of <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> patients </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000726'>Dementia</z:hpo> is principally diagnosed into <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) </plain></SENT>
<SENT sid="5" pm="."><plain>In older patients, the <z:e sem="disease" ids="C0221505" disease_type="Disease or Syndrome" abbrv="">brain lesions</z:e> associated with each <z:mpath ids='MPATH_596'>pathological process</z:mpath> often occur together </plain></SENT>
<SENT sid="6" pm="."><plain>Regional brain microvascular abnormalities appear before <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> and <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The coexistence of AD and VaD pathology is often termed mixed <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>AD and VaD <z:e sem="disease" ids="C0221505" disease_type="Disease or Syndrome" abbrv="">brain lesions</z:e> interact in important ways to decline cognition, suggesting common pathways of the two <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="32395">Arachidonate</z:chebi> cascade is one of the converged intracellular signal transductions between AD and VaD </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="79" ids="53407">PLA</z:chebi>(2) from mammalian sources are classified as secreted (sPLA(2)), Ca(2+)-dependent, cytosolic (cPLA(2)) and Ca(2+)-independent cytosolic <z:chebi fb="79" ids="53407">PLA</z:chebi>(2) (iPLA(2)) </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="79" ids="53407">PLA</z:chebi>(2) activity can be regulated by calcium, by phosphorylation, and by <z:chebi fb="4" ids="48705">agonists</z:chebi> binding to G-protein-coupled receptors </plain></SENT>
<SENT sid="12" pm="."><plain>cPLA(2) is upregulalted in AD, but iPLA(2) is downregulated </plain></SENT>
<SENT sid="13" pm="."><plain>On the other hand, sPLA(2) is increased in animal models for VaD </plain></SENT>
<SENT sid="14" pm="."><plain>COX-2 is induced and <z:chebi fb="0" ids="26337">PGD</z:chebi>(2) are elevated in both AD and VaD </plain></SENT>
<SENT sid="15" pm="."><plain>This review presents evidences for central roles of <z:chebi fb="79" ids="53407">PLA</z:chebi>(2)s, COXs and PGs in the <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>